IRVINE, CA / ACCESSWIRE / November 13, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 million ...

CHICAGO, IL / ACCESSWIRE / November 13, 2024 / Hopscotch Primary Care ("Hopscotch" or the "Company"), an innovator delivering technology-enabled primary care to rural communities, is proud to announce ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...

Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...

Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024 / ...

SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value oncology indicationsOngoing progress towards first in human clinical study for ...

Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc.

GAT Sport® Reclaims GNC Shelves and Introduces Its Newest Nitraflex® ULTRA Pre-Workout in a Power Play That Strengthens Both ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes that Centessa Pharmaceuticals has initiated a Phase 2 trial of ORX750, an ...

TrakCel, a provider of integrated cell and gene therapy (CGT) orchestration solutions for the precise management, control and tracking of CGTs has today announced that its orchestration platform ...